Its not too late to invest in this top biotech stock....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Vertex dominates the cystic fibrosis market today....…
Vertex Pharmaceuticals (VRTX) first-quarter 2023 earnings and sales beat estimates. Management reiterates financial guidance for 2023....…
2. Mai 2023 - Vancouver, British Columbia / IRW-Press / - Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…
One big drugmakers pain translates into another big drugmakers gain....…
VRTX earnings call for the period ending March 31, 2023....…
Kewalramani, Reshma - Vorstand - Tag der Transaktion: 2023-04-27...…
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) released earnings for first quarter that decreased from the same period last…
Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $331.93, marking a -0.27% move from the previous day....…
Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCI are included in this Analyst Blog....…
Todays Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Vertex Pharmaceuticals Incorporated (VRTX) and…
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-04-12...…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $326.37, marking a +0.47% move from the previous day....…
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-04-04...…
The average brokerage recommendation (ABR) for Vertex (VRTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…
bluebird, Oncternal Therapeutics, Avidity, Ascendis and Vertex Pharmaceuticals are included in this Analyst Blog....…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $316.33, marking a +0.4% move from the previous day....…
These stocks look reasonably priced considering their future prospects....…
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-24...…
Vertex Therapeutics (VRTX) enters into a licensing agreement with CRISPR for the latters gene-editing technology to accelerate the development of…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $308.47, marking a -1.88% move from the previous day....…
Latest Ratings for VRTX
DateFirmActionFromTo Feb 2022RBC CapitalDowngradesOutperformSector Perform Jan 2022BMO CapitalUpgradesMarket PerformOutperform Dec 2021Wells FargoInitiates Coverage OnOverweight
…
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-03-16...…
20. März 2023. Vancouver, British Columbia / IRW-Press / Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FWB: AA3)…
According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after…
VANCOUVER, British Columbia, March 20, 2023 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX | OTC: VTECF |…
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $295.77, moving -1.62% from the previous trading session....…
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-13...…
Wagner, Charles F Jr - Vorstand - Tag der Transaktion: 2023-03-10...…
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $287.24, marking a +0.13% move from the previous day....…
Vertex Pharmaceuticals (VRTX) receives FDA clearance to begin clinical development of VX-264, which has the potential to treat type I…
Vertex (VRTX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Incorporated (VRTX) announced the FDA has cleared the Investigational New Drug Application for VX-264,…
read more...…
Tatsis, Ourania - Vorstand - Tag der Transaktion: 2023-02-27...…
Arbuckle, Stuart A. - Vorstand - Tag der Transaktion: 2023-02-22...…
Altshuler, David - Vorstand - Tag der Transaktion: 2023-02-21...…
Arbuckle, Stuart A. - Vorstand - Tag der Transaktion: 2023-02-21...…
JPMorgan Chase, Elevance Health, Vertex Pharmaceuticals, Sony Group and General Mills are part of the Zacks top Analyst Blog....…
Todays Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Elevance Health, Inc.…
Altshuler, David - Vorstand - Tag der Transaktion: 2023-02-14...…
Tatsis, Ourania - Vorstand - Tag der Transaktion: 2023-02-13...…
Sanna, Bastiano - Vorstand - Tag der Transaktion: 2023-02-13...…
The drugmaker outperformed the broad market by a mile in 2022, but could there be further gains?...…
Boston (www.aktiencheck.de) - Rating-Update:
David Risinger, Analyst von SVB Securities, stuft die Aktie des Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN…
Both stocks should be winners if gene-editing therapy exa-cel wins regulatory approvals....…
Altshuler, David - Vorstand - Tag der Transaktion: 2023-02-06...…